首页 › 基金 › Integral Health Asset Management, LLC › SYRE
Integral Health Asset Management, LLC 对 SYRE 的持仓历史
SPYRE THERAPEUTICS INC · 医疗保健
Integral Health Asset Management, LLC 在 Q2 2026 的 13F 申报中披露持有 SYRE(SPYRE THERAPEUTICS INC)325,000 股,市值约 US$28.9M,约占其申报组合的 1.30%,在其申报持仓中市值排名第 25 位。 Integral Health Asset Management, LLC 最近 10 个申报季度中有 3 个季度披露了 SYRE 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Integral Health Asset Management, LLC 对 SYRE 的持仓演变
Integral Health Asset Management, LLC 于 Q1 2024 首次披露 SYRE 持仓:100,000 股(约 US$3.8M)。 该持仓在 Q2 2026 达到峰值 325,000 股,市值约 US$28.9M。 在 3 次申报中,Integral Health Asset Management, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 325,000 股、市值约 US$28.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 100.00K | $3.79M | 新进 |
| Q2 2024 | 100.00K | $2.35M | 持有 |
| Q2 2026 | 325.00K | $28.85M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SYRE 与 13F 数据
SYRE(SPYRE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 70 只申报持有 SYRE,申报仓位最大的包括:PERCEPTIVE ADVISORS LLC (US$383.5M), RTW INVESTMENTS, LP (US$377.5M), Paradigm Biocapital Advisors LP (US$341.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SYRE 的基金
- PERCEPTIVE ADVISORS LLC 4.32M 股 · $383.48M · Q2 2026
- RTW INVESTMENTS, LP 4.25M 股 · $377.49M · Q2 2026
- Paradigm Biocapital Advisors LP 3.84M 股 · $340.98M · Q2 2026
- Venrock Adviser, LLC 2.99M 股 · $265.05M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.80M 股 · $248.51M · Q2 2026
- TCG Crossover Management, LLC 1.90M 股 · $168.73M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.89M 股 · $167.99M · Q2 2026
- Remedium Capital Partners, LLC 1.46M 股 · $129.99M · Q2 2026
- Affinity Asset Advisors, LLC 1.28M 股 · $113.56M · Q2 2026
- Siren, L.L.C. 968.60K 股 · $85.99M · Q2 2026
- BRAIDWELL LP 879.47K 股 · $78.08M · Q2 2026
- Commodore Capital LP 846.79K 股 · $75.18M · Q2 2026
更多关于 Integral Health Asset Management, LLC
常见问题
How long has Integral Health Asset Management, LLC held SYRE?
Integral Health Asset Management, LLC has disclosed SYRE holdings in 3 of the last 10 reported quarters, going back to Q1 2024.
What is Integral Health Asset Management, LLC's current position in SYRE?
As of Q2 2026, Integral Health Asset Management, LLC holds 325.00K shares of SYRE (SPYRE THERAPEUTICS INC), valued at $28.85M, representing 1.30% of its reported portfolio and ranking #25.
Has Integral Health Asset Management, LLC been buying or selling SYRE?
In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC newly opened its position in SYRE. The position peaked in Q2 2026 at 325.00K shares.
Which other funds hold SYRE?
Other major institutional holders of SYRE include PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.